US Stock MarketDetailed Quotes
CLVLY CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV
- 10.098
- +0.103+1.03%
15min DelayTrading May 6 14:04 ET
505.95MMarket Cap26.64P/E (TTM)
10.380High10.000Low2.16KVolume10.380Open9.995Pre Close21.73KTurnover0.00%Turnover Ratio25.83P/E (Static)50.10MShares13.51152wk High4.34P/B505.95MFloat Cap8.54052wk Low0.03Dividend TTM50.10MShs Float31.289Historical High0.34%Div YieldTTM3.80%Amplitude8.540Historical Low10.049Avg Price1Lot Size
CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K | -100.79%-3.44K |
| Net PPE purchase and sale | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K | 88.86%-3.44K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -136.52%-1.03M | 49.15%-434.44K | 3.88%-854.33K | -245.02%-888.83K | -242.93%-257.62K | -11.33%-75.12K | 31.18%-67.48K | -816.62%-98.05K | -211.32%-10.7K | -100.79%-3.44K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -48.97%-2.24M | -1.61%-1.5M | 0.40%-1.48M | -44.17%-1.49M | -1.03M | -98.99%85.08K | 3,666.67%8.39M | -96.76%222.7K | 9.67%6.88M | |
| Net issuance payments of debt | ---- | ---- | ---- | 74.83%-18.5K | ---73.51K | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | -98.97%85.08K | 3,626.65%8.3M | -96.76%222.7K | 9.67%6.88M |
| Cash dividends paid | -60.00%-1.98M | 0.00%-1.24M | -0.92%-1.24M | -27.88%-1.22M | ---957.16K | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | 1.78%-263.72K | -34.06%-268.49K | 17.70%-200.28K | ---243.34K | ---- | ---- | ---- | --89.12K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -48.97%-2.24M | -1.61%-1.5M | 0.40%-1.48M | -44.17%-1.49M | ---1.03M | ---- | -98.99%85.08K | 3,666.67%8.39M | -96.76%222.7K | 9.67%6.88M |
| Net cash flow | ||||||||||
| Beginning cash position | 46.94%121.51M | 23.89%82.69M | 22.99%66.75M | 49.92%54.27M | 52.40%36.2M | 71.56%23.75M | 30.95%13.84M | -27.71%10.57M | 16.36%14.63M | -1.18%12.57M |
| Current changes in cash | -11.31%33.64M | 124.09%37.93M | 43.29%16.93M | -31.19%11.81M | 47.77%17.17M | 16.95%11.62M | 205.36%9.93M | 175.35%3.25M | -308.62%-4.32M | 1,245.93%2.07M |
| Effect of exchange rate changes | 87.72%1.66M | 189.92%884.21K | -248.07%-983.32K | -26.42%664.08K | 9.00%902.48K | 3,174.37%827.93K | -241.53%-26.93K | -92.81%19.03K | 2,146.58%264.52K | -142.48%-12.93K |
| End cash Position | 29.05%156.81M | 46.94%121.51M | 23.89%82.69M | 22.99%66.75M | 49.92%54.27M | 52.40%36.2M | 71.56%23.75M | 30.95%13.84M | -27.71%10.57M | 16.36%14.63M |
| Free cash flow | -9.01%35.88M | 114.25%39.44M | 38.41%18.41M | -26.92%13.3M | 56.64%18.2M | 17.96%11.62M | 291.81%9.85M | -13.06%-5.13M | 5.62%-4.54M | 30.49%-4.81M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg